SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-010519
Filing Date
2021-05-05
Accepted
2021-05-05 16:05:45
Documents
12
Period of Report
2021-05-05
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37903
  Complete submission text file 0001493152-21-010519.txt   205741

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atrx-20210505.xsd EX-101.SCH 3196
3 XBRL LABEL FILE atrx-20210505_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE atrx-20210505_pre.xml EX-101.PRE 22717
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3225
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 21893202
SIC: 2834 Pharmaceutical Preparations